• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 144 filed by Cellebrite DI Ltd.

    2/28/25 4:04:55 PM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology
    Get the next $CLBT alert in real time by email
    Form 144 Filer Information UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Form 144

    NOTICE OF PROPOSED SALE OF SECURITIES
    PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

    FORM 144

    144: Filer Information

    Filer CIK
    0001547134
    Filer CCC
    XXXXXXXX
    Is this a LIVE or TEST Filing? Radio button checked LIVE Radio button not checked TEST

    Submission Contact Information

    Name
    Phone
    E-Mail Address

    144: Issuer Information

    Name of Issuer
    CELLEBRITE DI LTD.
    SEC File Number
    001-40772
    Address of Issuer
    94 Shlomo Shmelzer Road
    Petah Tikva
    ISRAEL
    4970602
    Phone
    972 73 394-8000
    Name of Person for Whose Account the Securities are To Be Sold
    DAVID N. GEE
    See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

    Relationship to Issuer
    Officer

    144: Securities Information

    Title of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To Be SoldAggregate Market ValueNumber of Shares or Other Units OutstandingApproximate Date of SaleName the Securities Exchange
    Common
    Morgan Stanley Smith Barney LLC Executive Financial Services
    1 New York Plaza
    8th Floor
    New York � NY � 10004
    7085131720.7821818624802/28/2025
    NASDAQ


    Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

    144: Securities To Be Sold

    Title of the ClassDate you AcquiredNature of Acquisition TransactionName of Person from Whom AcquiredIs this a Gift?Date Donor AcquiredAmount of Securities AcquiredDate of PaymentNature of Payment *
    Common12/30/2024Performance SharesIssuerCheckbox not checked708512/30/2024Not Applicable

    * If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



    Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

    144: Securities Sold During The Past 3 Months

    Name and Address of SellerTitle of Securities SoldDate of SaleAmount of Securities SoldGross Proceeds
    DAVID N. GEE
    94 Shlomo Shmelzer Road
    Petah Tikva � L3 � 4970602
    Common12/27/2024426394393.48

    144: Remarks and Signature

    Remarks
    Date of Notice
    02/28/2025

    ATTENTION:

    The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
    Signature
    /s/ David Gee

    ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

    Get the next $CLBT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CLBT

    DatePrice TargetRatingAnalyst
    3/28/2024$13.00 → $13.50Buy
    Needham
    3/13/2024Mkt Perform → Outperform
    William Blair
    2/16/2024$9.00 → $12.00Neutral → Buy
    BofA Securities
    7/19/2023$11.00Buy
    Craig Hallum
    8/12/2022$6.50 → $6.00Buy → Neutral
    BofA Securities
    8/12/2022Outperform → Mkt Perform
    William Blair
    2/24/2022$10.50Overweight
    JP Morgan
    2/11/2022$10.50Buy
    Deutsche Bank
    More analyst ratings

    $CLBT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by Cellebrite DI Ltd.

      SC 13D/A - Cellebrite DI Ltd. (0001854587) (Subject)

      9/17/24 4:33:52 PM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology
    • Amendment: SEC Form SC 13D/A filed by Cellebrite DI Ltd.

      SC 13D/A - Cellebrite DI Ltd. (0001854587) (Subject)

      8/29/24 6:07:01 PM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology
    • SEC Form SC 13G/A filed by Cellebrite DI Ltd. (Amendment)

      SC 13G/A - Cellebrite DI Ltd. (0001854587) (Subject)

      3/12/24 12:38:56 PM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology

    $CLBT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Needham reiterated coverage on Cellebrite DI with a new price target

      Needham reiterated coverage of Cellebrite DI with a rating of Buy and set a new price target of $13.50 from $13.00 previously

      3/28/24 8:25:08 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology
    • Cellebrite DI upgraded by William Blair

      William Blair upgraded Cellebrite DI from Mkt Perform to Outperform

      3/13/24 7:29:30 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology
    • Cellebrite DI upgraded by BofA Securities with a new price target

      BofA Securities upgraded Cellebrite DI from Neutral to Buy and set a new price target of $12.00 from $9.00 previously

      2/16/24 7:23:02 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology

    $CLBT
    Leadership Updates

    Live Leadership Updates

    See more

    $CLBT
    SEC Filings

    See more
    • Cellebrite Appoints Michael D. Capellas to Board of Directors as Lead Independent Director

      TYSONS CORNER, Va. and PETAH TIKVA, Israel, Jan. 06, 2025 (GLOBE NEWSWIRE) --  Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced a series of Board updates to support the Company's continued growth into 2025 and beyond. As previously detailed on November 6, 2024, Thomas E. Hogan has been appointed interim CEO to begin 2025 as part of a planned leadership transition. In conjunction with stepping into this position, Mr. Hogan remains on the Company's Board of Directors and plans to revert to his position as chairman upon the eventual appointment of a new CEO. As part of Cellebrite's ongoing commitment to

      1/6/25 8:00:00 AM ET
      $CLBT
      $CSCO
      Computer Software: Prepackaged Software
      Technology
      Computer Communications Equipment
      Telecommunications
    • Yossi Carmil to Step Down as CEO After Nearly 20 Years

      TYSONS CORNER, Va. and PETAH TIKVA, Israel, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced a planned leadership transition following Yossi Carmil's decision to step down from his current role as CEO and as a member of the Board of Directors by December 31, 2024. The Board has initiated a formal search for a new CEO, retaining an executive recruiting firm to advance this effort. Thomas E. Hogan, Cellebrite's executive chairman, will serve as interim CEO upon Carmil's departure and until the search is complete and a new CEO joins Cellebrite. "Cellebrite is indebted to

      11/6/24 8:20:00 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology
    • Cellebrite Appoints Tech Veteran Troy K. Richardson to Board of Directors

      TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier digital investigative solutions for the public and private sectors, announced today that Troy Richardson has joined its board of directors, effective August 13, 2024. Mr. Richardson is a seasoned technology executive with more than 30 years of experience in leading, scaling and transforming global organizations. He currently serves on the Unisys Corporation (NYSE:UIS) Board of Directors and previously served as a Director of the Board for Carestream Dental. Mr. Richardson was president of the Digital Thread group at PTC Inc. (NASDAQ:PTC) from 2021 until 2022

      8/14/24 7:00:00 AM ET
      $CLBT
      $PTC
      $UIS
      Computer Software: Prepackaged Software
      Technology
      EDP Services
    • Amendment: SEC Form SCHEDULE 13D/A filed by Cellebrite DI Ltd.

      SCHEDULE 13D/A - Cellebrite DI Ltd. (0001854587) (Subject)

      3/20/25 4:30:03 PM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 20-F filed by Cellebrite DI Ltd.

      20-F - Cellebrite DI Ltd. (0001854587) (Filer)

      3/18/25 7:04:55 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 144 filed by Cellebrite DI Ltd.

      144 - Cellebrite DI Ltd. (0001854587) (Subject)

      2/28/25 4:04:55 PM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology

    $CLBT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Cellebrite Unveils Spring 2025 Release to Accelerate Global Investigations

      TYSONS CORNER, Va. and PETAH TIKVA, Israel, May 06, 2025 (GLOBE NEWSWIRE) --  Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced its Spring 2025 Release, featuring a new cloud foundation and AI-powered innovations across its portfolio. These enhancements are already playing an important role in helping customers modernize their digital workflows, speed up their investigations and elevate operational productivity and efficiency. The Spring 2025 Release introduces the Cellebrite Cloud, which delivers a purpose-built user experience that scales investigative capabilities and accelerates decision-making acro

      5/6/25 8:30:00 AM ET
      $AMZN
      $CLBT
      Catalog/Specialty Distribution
      Consumer Discretionary
      Computer Software: Prepackaged Software
      Technology
    • Cellebrite to Report First-Quarter 2025 Financial Results on May 14, 2025

      TYSONS CORNER, Va. and PETAH TIKVA, Israel, April 10, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its first-quarter 2025 financial results before market open on Wednesday, May 14, 2025. Later that same morning, Cellebrite will host a live conference call and webcast to review the Company's financial results for the first quarter of 2025 and discuss its full-year 2025 outlook. Relevant details include: Date:Wednesday, May 14, 2025Time:8:30 a.m. ETCall-In Number:203-518-9783 / 800-267-6316Conference ID:CLBTQ125Event URL:https://investors.cellebrite.com/events/

      4/10/25 8:30:00 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology
    • 10 Winners Awarded "Justies" at Cellebrite's First-Ever Digital Justice Awards

      TYSONS CORNER, Va. and PETAH TIKVA, Israel, April 01, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in Digital Investigative (DI) solutions for the public and private sectors, awarded ten winners "Justies" at the Company's inaugural Digital Justice Awards. Held at The National Law Enforcement Museum in Washington, DC, Cellebrite rolled out the orange carpet to celebrate some of the brightest minds and sharpest technical skillsets in digital investigations. "It was inspiring to celebrate those who tirelessly protect their communities," said Tom Hogan, Cellebrite's chief executive officer. "The evening shined a bright light on the courage, passion and dedication of thes

      4/1/25 8:30:00 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology

    $CLBT
    Financials

    Live finance-specific insights

    See more
    • Cellebrite to Report First-Quarter 2025 Financial Results on May 14, 2025

      TYSONS CORNER, Va. and PETAH TIKVA, Israel, April 10, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its first-quarter 2025 financial results before market open on Wednesday, May 14, 2025. Later that same morning, Cellebrite will host a live conference call and webcast to review the Company's financial results for the first quarter of 2025 and discuss its full-year 2025 outlook. Relevant details include: Date:Wednesday, May 14, 2025Time:8:30 a.m. ETCall-In Number:203-518-9783 / 800-267-6316Conference ID:CLBTQ125Event URL:https://investors.cellebrite.com/events/

      4/10/25 8:30:00 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology
    • Cellebrite Announces Fourth-Quarter and Full-Year 2024 Results

      Company delivers "Rule of 50" Performance in 2024 with 25% ARR growth and 25% adjusted EBITDA margin Fourth-quarter 2024 revenue of $109.0 million grew 17% primarily due to21% growth in subscription revenue ARR grew 25% to $395.9 million Fourth-quarter 2024 adjusted EBITDA of $28.8 million, 26.4% adjusted EBITDA margin TYSONS CORNER, Va. and PETAH TIKVA, Israel, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced financial results for the three and twelve months ending December 31, 2024. "Cellebrite delivered a solid fourth-quarter performance to cap an excellent 2024

      2/13/25 7:00:00 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology
    • Cellebrite to Report Fourth-Quarter and Fiscal Year 2024 Financial Results on February 13, 2025

      TYSONS CORNER, Va. and PETAH TIKVA, Israel, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its fourth-quarter and fiscal year 2024 financial results before market open on Thursday, February 13, 2025. Later that same morning, Cellebrite will host a live conference call and webcast to review the Company's financial results for the fourth quarter of 2024 and discuss its 2025 outlook. Relevant details include: Date:Thursday, February 13, 2025Time:8:30 a.m. ETCall-In Number:203-518-9783 / 800-267-6316Conference ID:         CLBTQ424Event URL:https://investor

      1/10/25 8:00:00 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology